ATRX |
Alpha-Thalassemia/intellectual Disability syndrome X-linked. |
AUC |
Area under the ROC Curve. |
BRAF |
B-Raf proto-oncogene. |
BRCA1 |
Breast cancer susceptibility gene 1. |
BRCA2 |
Breast cancer susceptibility gene 2. |
CA125 |
Carbohydrate antigen 125). |
CDKN2A |
Cyclin-dependent kinase inhibitor 2A. |
CEA |
Carcinoembryonic antigen. |
CNN |
Convolutional Neural Network. |
CT |
Computed tomography. |
DCE |
Dynamic contrast enhanced. |
DNA |
Deoxyribonucleic acid. |
ER |
Estrogen-receptor. |
FDG PET-CT |
Fluorodeoxyglucose PET/CT. |
FLAIR |
Fluid-attenuated inversion recovery. |
GBM |
Glioblastoma. |
GSEA |
Gene Set Enrichment Analysis. |
HCC |
Hepatocellular carcinoma. |
HER2 |
Human epidermal growth factor receptor 2. |
HGSOC |
High-grade serous ovarian cancer. |
ICC |
Intrahepatic cholangiocarcinoma. |
INHBB |
Inhibin subunit beta B. |
KRAS |
Carcinogenic Kirsten rat sarcoma viral oncogene homolog. |
KEGG |
Kyoto Encyclopedia of Genes and Genomes. |
MGMT |
O6-methylguanine-DNA methyltransferase. |
NF1 |
Neurofibromatosis 1. |
PDGFRA |
Platelet-derived growth factor receptor A. |
PD-L1 |
Programmed death ligand 1. |
PET |
Positron emission tomography. |
PIK3CA |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha. |
PR |
Progesterone-receptor. |
PTEN |
Phosphatase and tensin homologue. |
RB1 |
Retinoblastoma protein. |
SUV |
Standardized Uptake Value. |
TACE |
Trans arterial chemoembolization. |
TNBC |
Triple-negative breast cancer. |
TP53 |
Tumor protein p53. |
US |
Ultrasound. |